AMGEN INC·4

May 21, 7:02 PM ET

ISHRAK OMAR 4

4 · AMGEN INC · Filed May 21, 2026

Research Summary

AI-generated summary of this filing

Updated

Amgen Director Ishrak Omar Receives 665-Share RSU Award

What Happened

  • Ishrak Omar, a director of Amgen Inc. (AMGN), received a grant of 665 restricted stock units (RSUs) on 2026-05-19. The reported acquisition price is $0.00 (grant/award), so the Form 4 shows $0 cash paid. The award vested immediately and is payable in shares on a one-to-one basis under the company's director incentive plan.

Key Details

  • Transaction date: 2026-05-19; Report filed: 2026-05-21 (timely filing).
  • Transaction type/code: Award/Grant (A).
  • Shares reported: 665 RSUs granted at $0.00.
  • Footnote highlights:
    • F1: RSUs were granted under Amgen’s 2009 Director Incentive Program, vested immediately, and are paid in shares (director may elect deferral).
    • F2: The 665 shares include 418 dividend equivalents (DEs) credited to unvested RSUs and paid out in shares per the vesting schedule, with cash for any fractional share.
  • Shares owned after the transaction: not specified in the provided excerpt of the filing.

Context

  • This is an equity compensation award to a board member — not an open-market buy or sale. Awards to directors are routine compensation and do not necessarily signal a personal view on the stock. Deferred payout or immediate issuance depends on the director’s deferral election; DEs simply reflect dividend equivalents credited to the RSUs.

Insider Transaction Report

Form 4
Period: 2026-05-19
ISHRAK OMAR
Director
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-05-19+6657,358.736 total
Footnotes (2)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and vested immediately. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. Vested RSUs may be deferred by the director, in which case payment will occur according to the elected deferral schedule.
  • [F2]These shares include 418 DEs granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Signature
/s/ S. Omar Ishrak|2026-05-20

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT